Editorial Board

Cell & Cellular Life Sciences Journal

Home CCLSJ Editorial Board Thian Chew

Share this profile

LinkedIn Twitter / X

✓ Link copied!

TC

Thian Chew

Editorial Board Member
Hong Kong University of Science & Technology Hong Kong Member since 2023

Biography

Thian Chew is Chairman&CEO of Invion Limited (ASX: IVX), a life-sciences company leading the development of PhotosoftTM technology, a next generation photodynamic therapy (PDT), used for treating a range of cancers and infectious diseases. He is also Co-Founder of Chronic Airway Therapeutics which develops novel therapies for chronic respiratory diseases. Thian is Managing Partner at Polar Ventures, and was Executive Director at Goldman Sachs (New York, Hong Kong) responsible for the firm’s proprietary investments. Prior to this he worked at Morgan Stanley’s Strategic Services Group (New York) and spent ten years at KPMG (Melbourne, Taipei, Sydney, Singapore) taking multiple roles across Asia Pacific including leading business transformation and post-merger integration programs. He holds an MBA, Wharton School (Palmer Scholar), MA (Lauder), Uni. Pennsylvania, and B. Information Systems, Monash University, and is Adjunct Professor at Hong Kong University of Science & Technology’s Schools of Business as well as Life Sciences.

Research Interests

Life Sciences Clinical Research Covering Oncology Infectious Diseases COPD

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?